SCHEMBL4138286

SCHEMBL4138286

CCc1ccc2oc3cc4c(cc3c2c1)oc1ccccc14

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.57
CYP2D6 P10635 1/20 0.57
CYP2C19 P33261 1/20 0.57
PDE10A Q9Y233 7/20 0.50
MAPT P10636 3/20 0.50
AHR P35869 2/20 0.50
KDM4E B2RXH2 2/20 0.50
MEN1 O00255 2/20 0.50
ALDH1A1 P00352 2/20 0.50
HPGD P15428 2/20 0.50
KMT2A Q03164 2/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
PDE4D Q08499 1/20 0.47
POLB P06746 1/20 0.47
MAOA P21397 1/20 0.45
USP2 O75604 1/20 0.45
TSHR P16473 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10238647 0.96 CYP1A2 (0.60) CYP1A2CYP2D6CYP2C19PDE10AMAPT
SCHEMBL13529170 0.95 CYP1A2 (0.55) CYP1A2CYP2D6CYP2C19PDE10AMAPT
SCHEMBL1635502 0.91 TSHR (0.43) CYP1A2CYP2D6CYP2C19PDE10AMAPT
SCHEMBL10306815 0.89 AHR (0.53) CYP1A2CYP2D6CYP2C19MAPTAHR
SCHEMBL30810814 0.89 AHR (0.53) CYP1A2CYP2D6CYP2C19MAPTAHR
SCHEMBL13567590 0.86 CYP1A2 (0.50) CYP1A2CYP2D6CYP2C19PDE10AMAPT
SCHEMBL1636957 0.85 HSD17B10 (0.46) CYP1A2CYP2D6CYP2C19PDE10AMAPT
SCHEMBL24004483 0.84 CYP1A2 (0.53) CYP1A2CYP2D6CYP2C19PDE10AMAPT
SCHEMBL20040381 0.83 CYP1A2 (0.50) CYP1A2CYP2D6CYP2C19PDE10AMAPT
SCHEMBL30999865 0.83 MAOA (0.60) MAPTKDM4EMEN1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8409730-B2 Crosslinked pi-conjugated heteroacene compound for organic electroluminescence device and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2013-04-02 US disclosed
US-20120112629-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120112629-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME PPOX, EPCAM, ILK CYP1A2 2107/4885CYP2D6 2314/4885CYP2C19 1559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.